FGF23 and hyperphosphatemia: Both the phosphaturic and the 1,25(OH)2D3-lowering effect of FGF-23 protect against hyperphosphatemia by increasing urinary elimination of phosphate and reducing intestinal phosphate absorption, respectively [29,30] (Figure 2).